Odyssey Therapeutics, Inc. Common Stock (ODTX) — Stance & relative strength
ODTX
Odyssey Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
$18.06▲+1.46%
Neutral · stance 47
ODTX is not confirmed as a leader.
3m RS is unavailable, Market Stance is 47
Lenses litMarket-wide RS; lit = leaderboard
3 month—pctile
TODAY'S READ · AS OF 2026-06-26
As of 2026-06-26, Odyssey Therapeutics, Inc. Common Stock (ODTX) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.8%, relative volume 0.68×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
ODTX is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.
Sector RS percentile is not available for Healthcare at this snapshot. Leading sector status (threshold: Healthcare RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.
ODTX currently shows a 20-day average daily range (ADR%) of 7.8%. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
TickerStance computes ODTX's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what ODTX has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
ODTX most recently filed a 10-Q covering FY26 Q1 with the SEC on 2026-06-17. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.
§ Seasonality
Not enough history to compute monthly seasonality for ODTX.